Sarepta snags its partner's CSO, Louise Rodino-Klapac, to lead new gene therapy unit
Putting one more arrow in its muscular dystrophy quiver, Sarepta has snagged a top executive from one of its partners to lead the company’s newly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
